TAG Vice President Gopal Nadadur and Sam Ide Share a Piece on India’s Potential To Be a Resilient Hub for Diversified Pharmaceutical Supply Chains
As the BIOSECURE Act draft legislation winds its way through Congress, multinational pharmaceutical companies are re-examining their global R&D footprints and manufacturing supply chains. TAG VPs Gopal Nadadur and Sam Ide explain today in their Nikkei Asia op-ed that India still has some ways to go in offering itself as a true alternative destination to […]